Your European Platform to Forge Strategic Partnerships that Transform T-Cell Engager Therapeutics
As T-cell engagers rapidly redefine the future of immuno-oncology and expand into autoimmune disease, biopharma leaders are actively seeking partners who can help them overcome translational barriers, reduce toxicities, and accelerate safer, more potent therapies into the clinic. From antibody discovery and engineering to preclinical modelling and cytokine profiling, the demand for innovative platforms and services that enhance TCE design and development has never been greater.
The T-Cell Engager Therapeutics Summit Europe is the region’s only dedicated forum uniting decision-makers across oncology and autoimmunity. Partnering with us provides a powerful platform to position your company at the forefront of next-generation TCE innovation, showcase your solutions to optimize drug safety and efficacy, and connect directly with senior R&D leaders, CSOs, and VPs from top biopharma actively investing in novel engagers. By aligning with this summit, you’ll not only gain visibility with the industry’s key stakeholders but also forge strategic collaborations that shape the competitive landscape and drive the next era of immunotherapy.
What to Expect?
Position your company as a leader in supporting the development of next-generation TCEs across oncology and autoimmunity
Showcase your antibody discovery expertise to optimise CD3 affinity, tumour antigen selectivity, and co-stimulatory integration for enhanced safety and efficacy.
Demonstrate cutting-edge preclinical modelling platforms that improve the translatability of TCEs from bench to bedside, addressing challenges such as hyperactivated T cells and unrealistic tumour clearance.
Engage directly with decision-makers – from CSOs, VPs, and R&D leaders at top biopharma actively seeking partners to accelerate discovery, optimise TCE design, and expand therapeutic applications.
Highlight your cytokine assays and profiling solutions to enable developers to accurately assess CRS risk, immune activation, and safety margins earlier in development.
Key Services & Solutions
Our attendees from cell engager biopharma experts are looking for service and solution providers with capabilities in the below areas but not limited to:
- Antibody Discovery & Engineering – Platforms and services that optimise CD3 affinity, tumour antigen selectivity, and co-stimulatory integration to enhance safety, potency, and durability of T-cell engagers.
- Preclinical Modelling & Translational Platforms – Innovative in vitro and in vivo models that improve predictability and translatability, addressing challenges such as hyperactivated T cells, tumour clearance overestimation, and safety signal detection.
- Cytokine Profiling & Assays – Tools to accurately assess CRS risk, immune activation, and safety margins early in development, enabling smarter go/no-go decisions and better-informed clinical trial design.
Hear What Our Past Sponsors Have to Say
Host two of these per year! Just as you suggested. We didn't have enough time to speak with everyone. The quality of research, and breadth of audience spanning biotech and pharma was great.
Invenra
Intimate environment which made it easy to talk to other attendees
Applied Biomath
Attending Companies Include
Audience Composition
Company Type
Attendee Seniority
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Edward O’Keefe
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.